Johnson & Johnson Innovative Medicine ▲ Sign in to save

• ▲ Hanneke Schuitemaker

  Johnson & Johnson (Netherlands) Immunology and Microbiology
  31.1k

  citations

  88

  h-index

  85

  Aachen papers
• ▲ JERALD C. SADOFF

  Johnson & Johnson (Netherlands) Immunology and Microbiology
  25.2k

  citations

  76

  h-index

  52

  Aachen papers
• ▲ Macaya Douoguih

  Johnson & Johnson (Netherlands) Medicine
  8.4k

  citations

  35

  h-index

  63

  Aachen papers
• ▲ Jenny Hendriks

  Coalition for Epidemic Preparedness Innovations · Coalition for Epidemic Preparedness Innovations Medicine
  6.52k

  citations

  29

  h-index

  38

  Aachen papers
• ▲ Mathieu Le Gars

  Janssen (Netherlands) · Johnson & Johnson (Netherlands) Medicine
  6.2k

  citations

  22

  h-index

  42

  Aachen papers
• ▲ Mandy A. C. Jongeneelen

  Johnson & Johnson (United States) · Johnson & Johnson (Netherlands) Biochemistry, Genetics and Molecular Biology
  5.93k

  citations

  21

  h-index

  7

  Aachen papers
• ▲ Boerries Brandenburg

  Johnson & Johnson (United States) · Johnson & Johnson (Netherlands) Medicine
  3.9k

  citations

  23

  h-index

  10

  Aachen papers
• ▲ Daniel J Stieh

  Janssen (Netherlands) · Johnson & Johnson (Netherlands) Immunology and Microbiology
  1.7k

  citations

  20

  h-index

  26

  Aachen papers
• ▲ Griet A. Van Roey

  Janssen (Netherlands) Medicine
  377

  citations

  9

  h-index

  6

  Aachen papers

9 results

• Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

  2024 Nature Communications article Medicine SARS-CoV-2 and COVID-19 Research Open access

  13

  citations
• Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

  2025 iScience article Medicine SARS-CoV-2 and COVID-19 Research Open access

  1

  citations

2 results